Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T17:06:42.179Z.
Calculation as of: 2026-10-06T17:06:42.179Z.
Quote observation: 2026-10-06T17:05:10.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2576380beaab4b3cbce085b4235445012990db653f345db98d0cfe80ba67c11f
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | $52.46M | N/A | N/A | N/A | N/A |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $52.78M | N/A | N/A | N/A | N/A |
| biote Corp. (BTMD)vs › | $51.61M | 11.46x | 6.17x | 6.96x | 6.04x |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $50.48M | N/A | N/A | N/A | N/A |
| Spectral AI, Inc. (MDAI)vs › | $54.10M | N/A | N/A | N/A | N/A |
| Aldeyra The (ALDX)vs › | $53.20M | N/A | N/A | N/A | N/A |
| eXoZymes, Inc. (EXOZ)vs › | $51.42M | N/A | N/A | N/A | N/A |
| Envoy Medical, Inc. (COCH)vs › | $51.33M | N/A | N/A | N/A | N/A |
| ImageneBio Inc (IMA)vs › | $53.63M | N/A | N/A | N/A | N/A |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $50.99M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
